Gene mutation analysis in EGFR wild type NSCLC responsive to erlotinib: are there features to guide patient selection?
Ulivi P, Delmonte A, Chiadini E, Calistri D, Papi M, Mariotti M, Verlicchi A, Ragazzini A, Capelli L, Gamboni A, Puccetti M, Dubini A, Burgio MA, Casanova C, Crinò L, Amadori D, Dazzi C.
Ulivi P, et al.
Int J Mol Sci. 2014 Dec 31;16(1):747-57. doi: 10.3390/ijms16010747.
Int J Mol Sci. 2014.
PMID: 25561229
Free PMC article.